| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOMATERIALS.2013.09.094 |
| P698 | PubMed publication ID | 24125772 |
| P2093 | author name string | Hongliang Xin | |
| Xianyi Sha | |||
| Xinyi Jiang | |||
| Lingjun Zhu | |||
| Jijin Gu | |||
| Fengyi Du | |||
| Xiaoling Fang | |||
| Chunlai Feng | |||
| Yike Xie | |||
| Qiuyue Ren | |||
| P433 | issue | 1 | |
| P921 | main subject | nanoparticle | Q61231 |
| drug delivery | Q1392806 | ||
| P304 | page(s) | 518-529 | |
| P577 | publication date | 2013-10-11 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment | |
| P478 | volume | 35 |
| Q38838668 | Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology. |
| Q37687455 | Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats |
| Q60923343 | CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin |
| Q57173826 | Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance |
| Q38265614 | Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma |
| Q36307576 | Designing polymers with sugar-based advantages for bioactive delivery applications |
| Q89066364 | Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy |
| Q47433079 | Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials |
| Q30354734 | Dual-stimuli responsive and reversibly activatable theranostic nanoprobe for precision tumor-targeting and fluorescence-guided photothermal therapy. |
| Q91603860 | Emerging transporter-targeted nanoparticulate drug delivery systems |
| Q41513431 | Engineering the RNA-Nanobio Interface |
| Q64290782 | Exosomes derived from M1 macrophages aggravate neointimal hyperplasia following carotid artery injuries in mice through miR-222/CDKN1B/CDKN1C pathway |
| Q58764302 | Folate and Borneol Modified Bifunctional Nanoparticles for Enhanced Oral Absorption |
| Q28079663 | Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy |
| Q38708393 | Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery |
| Q90101402 | Glucose-installed biodegradable polymeric micelles for cancer-targeted drug delivery system: synthesis, characterization and in vitro evaluation |
| Q42379631 | Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain |
| Q38862946 | Harnessing nanomedicine for therapeutic intervention in glioblastoma. |
| Q58582432 | Highly Sensitive MoS-Indocyanine Green Hybrid for Photoacoustic Imaging of Orthotopic Brain Glioma at Deep Site |
| Q41843285 | Insulin-Based Regulation of Glucose-functionalized Nanoparticle Uptake in Muscle Cells. |
| Q91866088 | Investigation of the Role of Glucose Decorated Chitosan and PLGA Nanoparticles as Blocking Agents to Glucose Transporters of Tumor Cells |
| Q48035129 | L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2. |
| Q61813073 | Magnetic Mixed Micelles Composed of a Non-Ionic Surfactant and Nitroxide Radicals Containing a D-Glucosamine Unit: Preparation, Stability, and Biomedical Application |
| Q36137320 | Micellar emulsions composed of mPEG-PCL/MCT as novel nanocarriers for systemic delivery of genistein: a comparative study with micelles |
| Q40060003 | Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements |
| Q38275050 | Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance |
| Q90532393 | Nanotherapeutics Engineered to Cross the Blood-Brain Barrier for Advanced Drug Delivery to the Central Nervous System |
| Q91725291 | Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer |
| Q38818984 | Oestrone-targeted liposomes for mitoxantrone delivery via oestrogen receptor - synthesis, physicochemical characterization and in-vitro evaluation. |
| Q99608946 | Paclitaxel inhibits the migration of CD133+ U251 malignant glioma cells by reducing the expression of glycolytic enzymes |
| Q38857119 | Perspectives on Dual Targeting Delivery Systems for Brain Tumors. |
| Q42688132 | Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting |
| Q38577293 | Poly(trimethylene carbonate)-based polymers engineered for biodegradable functional biomaterials |
| Q48257781 | Poly(trimethylene carbonate)/Poly(malic acid) Amphiphilic Diblock Copolymers as Biocompatible Nanoparticles |
| Q26740580 | Progress and perspectives on targeting nanoparticles for brain drug delivery. |
| Q38269392 | Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier |
| Q39004466 | Sonication-induced formation of size-controlled self-assemblies of amphiphilic Janus-type polymers as optical tumor-imaging agents |
| Q92328419 | Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells - Possible Role of GLUT1 Transporter |
| Q101557486 | Surface receptor-mediated targeted drug delivery systems for enhanced cancer treatment: A state-of-the-art review |
| Q36392964 | Synthesis of a novel glucose capped gold nanoparticle as a better theranostic candidate. |
| Q37670254 | Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions |
| Q57291853 | Targeted Theranostic Nanoparticles for Brain Tumor Treatment |
| Q89427965 | Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy |
| Q38566898 | Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles |
| Q48182272 | The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis |
| Q26766079 | The sweet trap in tumors: aerobic glycolysis and potential targets for therapy |
| Q60048595 | Therapeutic nanoplatforms and delivery strategies for neurological disorders |
| Q28548580 | Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases |
| Q49472868 | Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types. |
| Q38206826 | Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery. |
| Q38998571 | Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma |
| Q27300789 | Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer |
| Q48095060 | Use of nanoparticles for glioblastoma treatment: a new approach |
| Q92126683 | Vitamin E-Loaded PLA- and PLGA-Based Core-Shell Nanoparticles: Synthesis, Structure Optimization and Controlled Drug Release |
Search more.